IntelliPharmaCeutics—Amended Form Of Proxy For Shareholders Meeting To Be Held On March 27, 2014
3/20/2014 9:21:20 AM
TORONTO, March 19, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that it has sent to registered shareholders an amended form of proxy for voting at its annual and special shareholders meeting to be held on March 27, 2014 (the "Meeting").
Help employers find you! Check out all the jobs and post your resume.
comments powered by